This invention discloses a strain of *
Lactobacillus johnsonii* DA0207 and its applications, belonging to the field of microbial technology. The *
Lactobacillus johnsonii* DA0207 provided by this invention was isolated from the
enteric coating of *Deinagkistrodon acutus*, and can grow well on
MRS agar medium. It is non-hemolytic, sensitive to a variety of common
antibiotics, and has good safety. This strain has good acid and bile salt tolerance, can adapt to the intestinal environment of humans and animals, and has
growth inhibitory effects on a variety of common
pathogenic bacteria.
Fermentation of *
Periplaneta americana*
powder with this strain significantly increased the content of various amino acids and
peptide active compounds in the
fermentation supernatant. The supernatant showed
growth inhibition and
apoptosis-promoting effects on colon
cancer cells. The supernatant also showed significant anti-inflammatory effects on DSS-induced
colitis in mice, significantly reducing the levels of
inflammatory factors. This provides a new avenue for the further development and utilization of functional foods, biological agents, and *
Periplaneta americana*.